Galapagos promotes Michele Manto

Company
Galapagos NV
Appointee name
Michele Manto
Country

Netherlands

Michele Manto has been promoted to the role of chief commercial officer at Galapagos NV as the company prepares for a regulatory decision and the expected launch of its lead product for rheumatoid arthritis filgotinib. Mr Manto has been working in a commercial capacity at Galapagos since 2017. Prior to this, he was head of marketing for rheumatology medicines at AbbVie Inc. He started his career at McKinsey & Company and holds an MBA from the business school INSEAD.

Galapagos announced the appointment on 23 January 2020.

Copyright 2020 Evernow Publishing Ltd